BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22384416)

  • 1. Comparison of follitropin β administered by a pen device with follitropin β administered by a conventional syringe in patients undergoing IVF-ET.
    Kang HJ; Kim CH; Ahn JW; Lee HA; Kim SH; Chae HD; Kang BM
    Clin Exp Reprod Med; 2011 Mar; 38(1):37-41. PubMed ID: 22384416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
    Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
    Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe.
    Craenmehr E; Bontje PM; Hoomans E; Voortman G; Mannaerts BM
    Reprod Biomed Online; 2001; 3(3):185-189. PubMed ID: 12513852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme - a retrospective study.
    Rama Raju GA; Suryanarayana K; Jaya Prakash G; Murali Krishna K
    J Clin Pharm Ther; 2008 Aug; 33(4):401-7. PubMed ID: 18613858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
    Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
    Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
    Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the administration of follitropin-beta with a pen device.
    Bruynesteyn K; Bonsel GJ; Braat DD; Fauser BC; Devroey P; van Genugten ML
    Reprod Biomed Online; 2005 Jul; 11(1):26-35. PubMed ID: 16102283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
    Welcker JT; Nawroth F; Bilger W
    Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
    Porter R; Kissel C; Saunders H; Keck C
    Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a fully automated injector for self-administration of follitropin alpha in an IVF/ICSI programme.
    Greco E; Polonio-Balbi P; Ferrero S; Baroni E; Ubaldi F; Rienzi L; Tesarik J
    Reprod Biomed Online; 2005 Oct; 11(4):415-20. PubMed ID: 16274597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
    Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
    Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
    Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
    Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
    Pang S; Kaplan B; Karande V; Westphal LM; Scott R; Givens C; Sacks P;
    Reprod Biomed Online; 2003 Oct; 7(3):319-26. PubMed ID: 14653893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
    Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
    Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients.
    Qiao J; Zhang Y; Liang X; Ho T; Huang HY; Kim SH; Goethberg M; Mannaerts B; Arce JC
    Hum Reprod; 2021 Aug; 36(9):2452-2462. PubMed ID: 34179971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer.
    Brinsden P; Akagbosu F; Gibbons LM; Lancaster S; Gourdon D; Engrand P; Loumaye E
    Fertil Steril; 2000 Jan; 73(1):114-6. PubMed ID: 10632423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotrophin products: empowering patients to choose the product that meets their needs.
    Weiss N
    Reprod Biomed Online; 2007 Jul; 15(1):31-7. PubMed ID: 17623531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.
    Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G
    Patient Prefer Adherence; 2014; 8():813-26. PubMed ID: 24940048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.